Clinical Trial Update: Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset

View source ↗

Summary

A clinical trial investigating genomic biomarkers for late-onset rheumatoid arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Centre Hospitalier Sud Francilien | Conditions: Rheumatoid Arthritis | Status: WITHDRAWN